Skip to content

CME Accredited · Live Online Webinar

CURE-ious beyond borders

The Emerging Markets Multiple Myeloma Summit

From evidence to everyday practice: the evolving frontline treatment of multiple myeloma, with interactive cases and live expert debate.

Date
Friday, 23 October 2026
Time
5:00 PM UAE · 6:30 PM IST

Webinar starts in

00 Days
00 Hours
00 Minutes
00 Seconds

Friday, 23 October 2026 · 5:00 to 8:00 PM UAE (GMT +4) · 6:30 PM IST (GMT +5:30)

11

Expert Faculty

9

Countries

3 Hours

Live and Interactive

CME

Accredited

About the summit

Frontline myeloma, from evidence to everyday practice

Join leading experts from across the Emerging Markets as we explore the evolving frontline treatment of multiple myeloma, from evidence to everyday practice, with interactive cases and live expert debate.

From evidence

The development, data and therapeutic integration of anti-CD38 antibodies, PIs and IMiDs in the frontline setting.

To everyday practice

Real-world clinical cases that bring frontline decision making to life across Emerging Markets.

Live expert debate

A moderated panel and open Q and A with faculty from nine countries.

Meet the experts

Faculty

Moderators

Dr. Mohamed Mohty

Dr. Mohamed Mohty

Full Professor of Hematology and Head of the Hematology and Cellular Therapy Department

Saint-Antoine Hospital and Sorbonne University

France

Dr. Amal Elbeihani

Dr. Amal Elbeihani

Consultant Hematologist

King Fahad Hospital, Medina Al Munawarah

Saudi Arabia

Dr. Romana Jassat

Dr. Romana Jassat

Clinical Hematologist at ABJ Oncology

Netcare Pretoria East Hospital

South Africa

Dr. Mohamed Abu Haleeqa

Dr. Mohamed Abu Haleeqa

Consultant Hematologist and BMT

Abu Dhabi Stem Cells Center

United Arab Emirates

Speakers

Dr. Ahmed Alhuraiji

Dr. Ahmed Alhuraiji

Consultant in Internal Medicine, Hematology, and Hematological Oncology

Kuwait Cancer Control Center (KCCC)

Kuwait

Dr. Khalil Al Farsi

Dr. Khalil Al Farsi

Senior Consultant, Hematology and BMT

Sultan Qaboos University Hospital (SQUH)

Oman

Dr. Mervat Mattar

Dr. Mervat Mattar

Professor of Internal Medicine and Clinical Hematology

Cairo University

Egypt

Dr. Ihab El Hemaidi

Dr. Ihab El Hemaidi

Consultant in Adult Hematology and Bone Marrow Transplantation (BMT)

Princess Noorah Oncology Center

Saudi Arabia

Dr. Ali Bazarbachi

Dr. Ali Bazarbachi

Professor of Medicine (Hematology and Oncology) and Cell Biology

Founding Director of the BMT Program at AUBMC

American University of Beirut Medical Center

Lebanon

Dr. Abdallah Abbadi

Dr. Abdallah Abbadi

Founder and Director of Stem Cell Therapy Center (CTC)

Professor and Senior Consultant of Hematology and Oncology

University of Jordan

Jordan

Dr. Omar Abduljalil

Dr. Omar Abduljalil

Consultant in Adult Hematology and Internal Medicine

King Fahad Specialist Hospital

Saudi Arabia

Programme

Agenda

Friday, 23 October 2026 · All times UAE (GMT +4), 4:00 PM KSA start · Hybrid, join live online

  1. 5:00 to 5:10 PM Welcome and Opening

    Welcome and Opening Remarks

    Welcome, objectives of the virtual summit and housekeeping for the online format.

    Asgar Rangoonwala, VP J&J IM Emerging Markets

  2. 5:10 to 5:20 PM Keynote

    Shaping the Next Frontier in Multiple Myeloma: J&JIM's Vision, Innovation Engine, and Future Pipeline

    Maria Jazra, Head of Medical Affairs Emerging Markets

  3. 5:20 to 5:40 PM Session 1

    From Past Innovations to Future Horizons in Multiple Myeloma Care

    Evolution of MM management, updates on disease parameters and treatment goals, and a glance into the future.

    Dr. Mohamed Mohty (France)

  4. 5:40 to 6:00 PM Session 2

    Anti-CD38 mAbs in Multiple Myeloma: Development, Evidence and Therapeutic Integration

    Key milestones, pivotal trials and integration into quadruplet regimens.

    Dr. Ahmed Alhuraiji (Kuwait)

    Moderator: Dr. Amal Elbeihani (KSA)

  5. 6:00 to 6:20 PM Session 3

    Practical Considerations in Frontline Multiple Myeloma: Anti-CD38 Antibodies, Proteasome Inhibitors and IMiDs

    Administration modalities, prevention and management of adverse events, outpatient and home-based care.

    Dr. Khalil Al Farsi (Oman)

    Moderator: Dr. Romana Jassat (South Africa)

  6. 6:20 to 6:30 PM Coffee break
  7. 6:30 to 7:20 PM Session 4 Interactive

    Interactive Clinical Case Discussion: The Real-World Face of Frontline Myeloma

    Live polling and case-based discussion on evidence-based therapeutic strategy selection.

    Dr. Mervat Mattar (Egypt)

    Dr. Ihab El Hemaidi (KSA)

    Moderator: Dr. Mohamed Abu Haleeqa (UAE)

  8. 7:20 to 7:55 PM Session 5 Interactive

    Live Panel and Q&A: Optimizing the Frontline Treatments

    Expert dialogue on optimal regimen selection and tailoring therapy to individual profiles, followed by audience Q&A.

    Dr. Ali Bazarbachi (Lebanon)

    Dr. Abdallah Abbadi (Jordan)

    Dr. Omar Abduljalil (KSA)

    Moderator: Dr. Mohamed Mohty (France)

  9. 7:55 to 8:00 PM Closing

    Closing Remarks: Key Takeaways

    Dr. Mohamed Mohty (France)

Reserve your place

Registration is quick and free. Secure your place at the CURE-ious Beyond Borders live webinar and receive your joining link by email.

  • CME accredited
  • Interactive cases
  • Live expert panel

Endorsed by

Emirates Society of Haematology

Supported by

Johnson and Johnson

Powered by

Meeting Minds Experts